These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23311938)

  • 21. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
    Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
    J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
    Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G
    Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
    Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
    J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice.
    Karmakar S; Banik NL; Ray SK
    Cancer; 2008 Feb; 112(3):596-607. PubMed ID: 18098270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.
    Ishida CT; Zhang Y; Bianchetti E; Shu C; Nguyen TTT; Kleiner G; Sanchez-Quintero MJ; Quinzii CM; Westhoff MA; Karpel-Massler G; Prabhu VV; Allen JE; Siegelin MD
    Clin Cancer Res; 2018 Nov; 24(21):5392-5406. PubMed ID: 30037819
    [No Abstract]   [Full Text] [Related]  

  • 27. Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation.
    Ishiuchi S; Yoshida Y; Sugawara K; Aihara M; Ohtani T; Watanabe T; Saito N; Tsuzuki K; Okado H; Miwa A; Nakazato Y; Ozawa S
    J Neurosci; 2007 Jul; 27(30):7987-8001. PubMed ID: 17652589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.
    Coutinho de Souza P; Mallory S; Smith N; Saunders D; Li XN; McNall-Knapp RY; Fung KM; Towner RA
    PLoS One; 2015; 10(8):e0134276. PubMed ID: 26248280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas.
    Shi L; Sun G; Zhang Y
    Aging (Albany NY); 2020 Nov; 12(23):23795-23807. PubMed ID: 33221748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models.
    Alami N; Page V; Yu Q; Jerome L; Paterson J; Shiry L; Leyland-Jones B
    Growth Horm IGF Res; 2008 Dec; 18(6):487-96. PubMed ID: 18502161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined treatment of pancreatic cancer xenograft with
    Aung W; Tsuji AB; Sudo H; Sugyo A; Ukai Y; Kouda K; Kurosawa Y; Furukawa T; Saga T; Higashi T
    World J Gastroenterol; 2017 Nov; 23(42):7551-7562. PubMed ID: 29204055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
    Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
    Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
    Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
    Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perampanel Inhibits Neuroblastoma Cell Proliferation Through Down-regulation of AKT and ERK Pathways.
    Nozawa A; Ozeki M; Matsuoka M; Nakama M; Yasue S; Endo S; Kawamoto N; Ohnishi H; Fukao T
    Anticancer Res; 2019 Jul; 39(7):3595-3599. PubMed ID: 31262884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
    Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
    J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the insulin-like growth factor 1 receptor by CHM-1 blocks proliferation of glioblastoma multiforme cells.
    Lin YC; Hou SC; Hung CM; Lin JN; Chen WC; Ho CT; Kuo SC; Way TD
    Chem Biol Interact; 2015 Apr; 231():119-26. PubMed ID: 25643584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
    Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
    BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.